Document is current
Any future updates will be listed below
-
Authors
Salehi, Mina
Bola, Rajan
de Jong, Nenke
Shih, Andrew W.
Garraway, Naisan
Dawe, Philip
- License Information
-
More Information
Article History
Received: 31 May 2022
Accepted: 20 June 2023
First Online: 1 July 2023
Declarations
:
: The study was approved by the ethics review board of the University of British Columbia (H18-00925).
: Not applicable.
: AWS has participated in an advisory board for CSL Behring for fibrinogen concentrate and as a consultant for Octapharma Canada in producing educational materials for the treatment of bleeding. PD has participated in an advisory board for CSL Behring for fibrinogen concentrate.
